Dynamics of the Prevalence of Pulmonary Diseases (COPD, Pneumonia, Bronchial Asthma) and Analysis of Risk Groups in the Republic of Karakalpakstan Odilov Diyorbek Dilshod oʻgʻli Janabaev Dauletbay Ixlasbay uli
Keywords:
COPD (Chronic Obstructive Pulmonary Disease), pneumonia, bronchial asthma, Form F-030/u, bronchiectasis, sarcoidosis, PM2.5 and PM10 particulate matterAbstract
This article analyzes the prevalence dynamics and epidemiological characteristics of bronchopulmonary system pathologies (COPD, pneumonia, bronchial asthma) among the population of the Republic of Karakalpakstan, an area of the Aral Sea environmental crisis, during the period of 2024–2025. A retrospective analysis was conducted based on the official statistical reports of regional medical institutions. The results of the study demonstrated a stable increase in overall respiratory morbidity by 17.5% within a single year. A demographic evaluation of the disease structure revealed a sharp surge in acute pneumonia by 74.8% and bronchial asthma by 31%. Multifactorial analysis established that women over the age of 60 constitute the highest clinical risk group. The obtained data medically substantiate the urgent need to optimize early screening systems, non-invasive diagnostics, and to develop targeted preventive pulmonological strategies in environmentally distressed regions.
Downloads
Published
Issue
Section
How to Cite
References
Ministry of Health of the Republic of Karakalpakstan. (2024). Population health and healthcare system indicators: Annual statistical compendium. Nukus. 142 p. [in Uzbek].
Ministry of Health of the Republic of Karakalpakstan. (2025). Reports and final medical-statistical references of treatment-prophylactic institutions. Nukus. 118 p. [in Uzbek].
Statistics Agency under the President of the Republic of Uzbekistan. (2026). Demographic indicators and population dynamics of the Republic of Karakalpakstan: Official report. Tashkent. [in Uzbek].
Gurbonov, A. K., & Ataniyazova, O. A. (2022). The impact of environmental factors on the pulmonological health of the population in the Aral Sea region. Medical Journal of Uzbekistan, (4), 34–39. [in Uzbek].
Mambetov, B. M., & Sharapov, K. A. (2023). Epidemiological characteristics and risk factors of chronic obstructive pulmonary disease in the conditions of Karakalpakstan. Journal of Pediatrics, (2), 75–81. [in Uzbek].
Jumaev, N. T., & Abdirov, Ch. A. (2024). Long-term dynamics of acute respiratory infections and pneumonia in ecological crisis regions. Issues of Control and Prophylaxis, 45–51. [in Uzbek].
World Health Organization. (2023). Chronic obstructive pulmonary disease (COPD): Regional epidemiological report on Central Asia. Geneva: WHO Guidelines. 88 p.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2024). Global strategy for the diagnosis, management, and prevention of COPD: 2024 report. Available from: https://goldcopd.org.
Global Initiative for Asthma (GINA). (2024). Global strategy for asthma management and prevention. GINA Report. Available from: https://ginasthma.org.
Environmental Protection Agency (EPA). (2023). Particulate matter (PM2.5 and PM10) ambient air quality standards and respiratory health risks. Washington: EPA Technical Brief.
Whitsel, E. A., et al. (2021). Air pollution, oxidative stress, and gender-specific susceptibility to chronic respiratory diseases. Environmental Health Perspectives, 129(8), Article 087002. https://doi.org/10.1289/EHP8432.
Soriano, J. B., et al. (2022). Global, regional, and national deaths, prevalence, disability-adjusted life years, and trends in chronic obstructive pulmonary disease and asthma, 1990–2020: A systematic analysis for the Global Burden of Disease Study. The Lancet Respiratory Medicine, 10(3), 223–244. https://doi.org/10.1016/S2213-2600(21)00511-7.
National Center for Biotechnology Information (NCBI). PubMed Central Repository. Pulmonology Research Section. Available from: https://pmc.ncbi.nlm.nih.gov/.
